Aragusterol A
Alternative Names: YTA 0040Latest Information Update: 08 Nov 2006
At a glance
- Originator Nonindustrial source; Taisho Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 13 Apr 1999 Preclinical development for Cancer in Japan (Unknown route)